G1 Therapeutics Inc.

10/07/2021 | Press release | Distributed by Public on 10/07/2021 06:05

Retrospective Analysis of Pooled Results from Three Studies Shows COSELA™ (Trilaciclib) Reduced Use of Supportive Care Interventions in Extensive Stage Small Cell Lung Cancer[...]